Chimeric mouse model for the infection of hepatitis B and C viruses

scientific article (publication date: 2013)

Chimeric mouse model for the infection of hepatitis B and C viruses is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...877298T
P356DOI10.1371/JOURNAL.PONE.0077298
P8608Fatcat IDrelease_7xrirtspmvfztecabwqf5glday
P3181OpenCitations bibliographic resource ID581185
P932PMC publication ID3796464
P698PubMed publication ID24155939
P5875ResearchGate publication ID258041682

P50authorJudith StiftQ58538468
Hans-Peter DienesQ114665089
P2093author name stringDragan Maric
Stephen M Feinstone
Abeba Tesfaye
Qingwen Cui
P2860cites workLong-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virusQ27469355
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon RechallengeQ27472882
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatmentQ27490974
Complete replication of hepatitis C virus in cell cultureQ27860934
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypesQ27861119
RAG-1-deficient mice have no mature B and T lymphocytesQ28592133
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Hepatitis C virus replication in mice with chimeric human liversQ29620650
Preliminary study of two antiviral agents for hepatitis C genotype 1.Q34030288
Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse modelsQ34140014
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.Q34307135
Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinomaQ35677500
Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytesQ35829671
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- miceQ36115197
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancerQ36812745
An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancerQ37620586
Prospects for prophylactic and therapeutic vaccines against the hepatitis C virusesQ37825527
Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infectionQ37858630
Animal models for the study of hepatitis C virus infection and related liver diseaseQ38005793
Animal models for hepatitis C.Q38086749
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trialQ42857015
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID miceQ42998132
Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assayQ43040150
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null respondersQ43041150
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titersQ45794085
Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver.Q50706733
Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes.Q51671636
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.Q52221306
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.Q52507854
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.Q53454854
P275copyright licenseCreative Commons CC0 LicenseQ6938433
P6216copyright statuscopyrighted, dedicated to the public domain by copyright holderQ88088423
P433issue10
P407language of work or nameEnglishQ1860
P921main subjecthepatitis BQ6853
P304page(s)e77298
P577publication date2013-01-01
P1433published inPLOS OneQ564954
P1476titleChimeric mouse model for the infection of hepatitis B and C viruses
P478volume8

Reverse relations

cites work (P2860)
Q54988623Animal Models to Study Hepatitis C Virus Infection.
Q26797836Animal models for the study of HCV
Q38788783Assessing the therapeutic potential of lab-made hepatocytes
Q35998324Determinants of hepatitis B and delta virus host tropism.
Q39215858Development of mouse models for analysis of human virus infections
Q64058174Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus
Q35140067Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model
Q38778496Experimental models of hepatitis B and C - new insights and progress
Q91907310Generation of functional human hepatocytes in vitro: current status and future prospects
Q28384465HCV infection-associated hepatocellular carcinoma in humanized mice
Q35270150Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Q92856183Humanized Mouse Models for the Study of Hepatitis C and Host Interactions
Q64966438In Vivo Model Systems for Hepatitis B Virus Research.
Q26799933Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems
Q38534533Modeling hepatitis B virus infection, immunopathology and therapy in mice
Q38354353Modeling malaria in humanized mice: opportunities and challenges
Q27469038Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
Q89108940Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
Q26991875Murine models of hepatitis C: what can we look forward to?
Q26783920Single and Multiple Gene Manipulations in Mouse Models of Human Cancer
Q35685210Study of viral pathogenesis in humanized mice
Q40409293Studying HBV Infection and Therapy in Immune-Deficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (Fah) Knockout Mice Transplanted with Human Hepatocytes
Q39545359The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.
Q41116856Viral non-coding RNA inhibits HNF4α expression in HCV associated hepatocellular carcinoma
Q34175159Visualizing hepatitis C virus infection in humanized mice